These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 12599251)

  • 1. Formation of steady-state oxygen gradients in vitro: application to liver zonation.
    Allen JW; Bhatia SN
    Biotechnol Bioeng; 2003 May; 82(3):253-62. PubMed ID: 12599251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro zonation and toxicity in a hepatocyte bioreactor.
    Allen JW; Khetani SR; Bhatia SN
    Toxicol Sci; 2005 Mar; 84(1):110-9. PubMed ID: 15590888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term maintenance of human hepatocytes in oxygen-permeable membrane bioreactor.
    De Bartolo L; Salerno S; Morelli S; Giorno L; Rende M; Memoli B; Procino A; Andreucci VE; Bader A; Drioli E
    Biomaterials; 2006 Sep; 27(27):4794-803. PubMed ID: 16753210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced oxygen delivery to primary hepatocytes within a hollow fiber bioreactor facilitated via hemoglobin-based oxygen carriers.
    Sullivan JP; Gordon JE; Bou-Akl T; Matthew HW; Palmer AF
    Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(6):585-606. PubMed ID: 18097786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cultivation of primary porcine hepatocytes in an OXY-HFB for use as a bioartificial liver device.
    Jasmund I; Langsch A; Simmoteit R; Bader A
    Biotechnol Prog; 2002; 18(4):839-46. PubMed ID: 12153319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The suitability of hepatocyte culture models to study various aspects of drug metabolism.
    Nussler AK; Wang A; Neuhaus P; Fischer J; Yuan J; Liu L; Zeilinger K; Gerlach J; Arnold PJ; Albrecht W
    ALTEX; 2001; 18(2):91-101. PubMed ID: 11378681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative measurement and control of oxygen levels in microfluidic poly(dimethylsiloxane) bioreactors during cell culture.
    Mehta G; Mehta K; Sud D; Song JW; Bersano-Begey T; Futai N; Heo YS; Mycek MA; Linderman JJ; Takayama S
    Biomed Microdevices; 2007 Apr; 9(2):123-34. PubMed ID: 17160707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hollow fiber bioreactor: new development for the study of contrast agent transport into hepatocytes by magnetic resonance imaging.
    Planchamp C; Ivancevic MK; Pastor CM; Vallée JP; Pochon S; Terrier F; Mayer JM; Reist M
    Biotechnol Bioeng; 2004 Mar; 85(6):656-65. PubMed ID: 14966807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-depth physiological characterization of primary human hepatocytes in a 3D hollow-fiber bioreactor.
    Mueller D; Tascher G; Müller-Vieira U; Knobeloch D; Nuessler AK; Zeilinger K; Heinzle E; Noor F
    J Tissue Eng Regen Med; 2011 Aug; 5(8):e207-18. PubMed ID: 21442764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling O2 transport within engineered hepatic devices.
    McClelland RE; MacDonald JM; Coger RN
    Biotechnol Bioeng; 2003 Apr; 82(1):12-27. PubMed ID: 12569620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microfluidic PDMS (polydimethylsiloxane) bioreactor for large-scale culture of hepatocytes.
    Leclerc E; Sakai Y; Fujii T
    Biotechnol Prog; 2004; 20(3):750-5. PubMed ID: 15176878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of flow on the detoxification function of rat hepatocytes in a bioartificial liver reactor.
    Roy P; Washizu J; Tilles AW; Yarmush ML; Toner M
    Cell Transplant; 2001; 10(7):609-14. PubMed ID: 11714195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a bioreactor with stacked sheet shaped organoids of primary hepatocytes.
    Kusumi T; Ishihara K; Mizumoto H; Nakazawa K; Ijima H; Funatsu K; Kajiwara T
    J Biosci Bioeng; 2009 May; 107(5):552-5. PubMed ID: 19393557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Liver cell culture in bioreactors for in vitro drug studies as an alternative to animal testing].
    Zeilinger K; Auth S; Unger J; Grebe A; Mao L; Petrik M; Holland G; Appel K; Nüssler A; Neuhaus P; Gerlach J
    ALTEX; 2000; 17(1):3-10. PubMed ID: 11103107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perfluorocarbon facilitated O(2) transport in a hepatic hollow fiber bioreactor.
    Chen G; Palmer AF
    Biotechnol Prog; 2009; 25(5):1317-21. PubMed ID: 19565662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing normoxic conditions in liver devices using enhanced gel matrices.
    Niu M; Clemens MG; Coger RN
    Biotechnol Bioeng; 2008 Apr; 99(6):1502-12. PubMed ID: 17969150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An in vitro hepatic zonation model with a continuous oxygen gradient in a microdevice.
    Sato A; Kadokura K; Uchida H; Tsukada K
    Biochem Biophys Res Commun; 2014 Oct; 453(4):767-71. PubMed ID: 25445587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational evaluation of oxygen and shear stress distributions in 3D perfusion culture systems: macro-scale and micro-structured models.
    Cioffi M; Küffer J; Ströbel S; Dubini G; Martin I; Wendt D
    J Biomech; 2008 Oct; 41(14):2918-25. PubMed ID: 18789444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transport in a grooved perfusion flat-bed bioreactor for cell therapy applications.
    Horner M; Miller WM; Ottino JM; Papoutsakis ET
    Biotechnol Prog; 1998; 14(5):689-98. PubMed ID: 9758657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low O2 metabolism of HepG2 cells cultured at high density in a 3D microstructured scaffold.
    Provin C; Takano K; Yoshida T; Sakai Y; Fujii T; Shirakashi R
    Biomed Microdevices; 2009 Apr; 11(2):485-94. PubMed ID: 19082898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.